News, Publications, and Podcasts Focus rounding on high-risk patients

Vasc-Alert News

Hemodialysis access risk score analysis with vasc alert
Featured

Prospective Evaluation of Remote Software Based Surveillance Supplementing Clinical Monitoring For Hemodialysis Vascular Access

Vasc-Alert was recently featured in a 12-month prospective study related to an article published earlier this year. This summary provides our perspective, from clinical staff, on the study's findings and related results. To view the full article, please read more by clicking here.

Summary of Prospective Evaluation of Remote Software-Based Surveillance Supplementing Clinical Monitoring for Hemodialysis Vascular Access

This study, "Prospective Evaluation of Remote Software-Based Surveillance Supplementing Clinical Monitoring For Hemodialysis Vascular Access," evaluated the impact of adding remote software surveillance (Vasc-Alert) to standard clinical monitoring for hemodialysis vascular access (VA). Below is a summary of the key vascular events observed in the study groups.

Methods

  • Study Population: 287 adult maintenance HD patients with permanent VA across 5 dialysis units were included.
  • Design: A 12-month prospective observational cohort study.
  • Intervention: Vasc-Alert was used in 2 units (Group 1) alongside routine clinical monitoring, while 3 units continued with standard care (Group 2).
  • Data Collected: Referrals for fistulograms, VA events (stenosis correction, thrombosis), access abandonment, and complication-free days (CFD) were tracked.

Key Findings

  • Preemptive Correction of Stenosis: Group 1 had 23 (28.1%) preemptive corrections compared to 40 (19.5%) in Group 2 (p=0.155).
  • Thrombosis Episodes: Group 1 had 6 (7.3%) thrombosis episodes versus 21 (10.2%) in Group 2 (p=0.587). Critically, 83% of thrombotic episodes in Group 1 occurred afterthe patient had been identified as high-risk and referred for a fistulogram but before the procedure could be performed, compared to only 19% in Group 2 (p=0.004). The median time from fistulogram request to thrombosis was 26 days.
  • Avoidable Thrombosis: This is a crucial metric. It refers to cases where thrombosis occurred after a patient was identified as high-risk and referred for a procedure (stenosis correction) but before the procedure could be performed. Group 1 had a much higher proportion of avoidable thrombosis (83% of all thrombosis events in the group) compared to Group 2 (19%). This difference was statistically significant (p=0.004).
  • Post-Intervention Primary Patency: Group 1 showed significantly better primary patency rates at both 3 and 6 months post-intervention (100% vs. 80% at 3 months, 100% vs. 62.2% at 6 months, p<0.001).
  • Complication-Free Days (CFD): Group 1 had significantly more CFD-extended (median 364 days) than Group 2 (median 362 days) (p=0.002).
  • Cost Analysis: The average VA-related cost per patient was £1600 for Group 1 and £1868 for Group 2.
  • Repeated Stenosis: Group 2 had 11 instances of repeated stenosis compared to none in Group 1. This difference was statistically significant (p=0.038).

Interpretation

  • Vasc-Alert's Potential: The data suggests that Vasc-Alert effectively identifies patients at risk for vascular events.
  • System Bottleneck: The high rate of avoidable thrombosis in Group 1 points to a significant bottleneck in the system, likely due to delays in scheduling and performing necessary procedures. This delay negates some potential benefits of early detection provided by Vasc-Alert.
  • Need for Resource Allocation: The study implies that simply implementing a surveillance tool is insufficient. Adequate resources, such as timely access to interventional radiology, are essential to act on the information provided by the surveillance system and improve patient outcomes.

Conclusion

The study suggests that Vasc-Alert, when used as a supplement to standard care, is associated with improved detection of high-risk VA, better primary patency rates, and more complication-free days. However, the study also highlights a critical bottleneck: delays in elective interventional radiology. The authors argue that improving the capacity for timely interventions (within 3 weeks of referral) is essential to fully realize the benefits of enhanced surveillance and prevent thrombosis while patients await procedures.

 


Credit

Nephron, DOI: 10.1159/0005436903

Published online: January 20, 2025